Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%

• Status: Not yet recruiting
• Trial end date: 2023-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The study aims to assess the impact of models of HCV care on HCV testing, treatment uptake and cure within Cairns. Point of care testing for HCV , with test and treat strategies will be offered within a primary care service.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Macfarlane Burnet Institute for Medical Research and Public Health Ltd
• Collaborators: Cairns Hinterland Health Hospital and Health Services; The University of Queensland
• Treatments: Sofosbuvir-velpatasvir drug combination

Criteria

Inclusion Criteria:

• attending primary health care service of CHHS aged 18 years or over

Exclusion Criteria: only for intervention arm test and treat

• Known to have hepatitis B or HIV infection

• Known to have cirrhosis

• Previous treatment with direct acting antivirals

• Previously received interferon-based hepatitis C treatment that did not work

• Women that are pregnant or breastfeeding

• Already receiving hepatitis C treatment.